Advantest Corporation (Kabushiki Kaisha Advantest) ADS Press Releases

ATE 
$11.34
*  
0.0701
0.62%
Get ATE Alerts
*Delayed - data as of Jul. 28, 2014 10:36 ET  -  Find a broker to begin trading ATE now
Exchange: NYSE
Industry: Technology
Community Rating:
View:    ATE Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Antibe Therapeutics Announces the Formation of Its Clinical Advisory Board
7/17/2014 7:30:00 AM - Business Wire

MEDIA ALERT: Advantest to Exhibit at SEMICON West 2014 in Moscone Center, San Francisco July 8-10, 2014
7/2/2014 3:05:00 AM - Market Wire

Advantest Introduces New PVI8 Floating Power Source to Enable Its V93000 Platform to Test High-Voltage and High-Current ICs
7/2/2014 3:05:00 AM - Market Wire

Advantest Files Annual Report Form 20-F with the SEC for the Year Ended March 31, 2014
6/27/2014 8:53:00 AM - Business Wire

Antibe Therapeutics Announces First Human Dose of ATB-346 in Phase I Clinical Trial
6/26/2014 8:54:00 PM - Business Wire

Advantest Introduces New Device Power Supply to Increase Versatility and Cost Efficiency of Its T2000 Test Platform
6/26/2014 3:05:00 AM - Market Wire

Advantest Enables Rapid SSD Development and Production Ramp With the Launch of Its New Flexible SSD Test Solution
6/25/2014 3:05:00 AM - Market Wire

Advantest Launches 1.6-Gbps Digital Module Enabling Protocol-Aware Testing With Powerful EDA-Link (FTA-Elink)
6/24/2014 3:05:00 AM - Market Wire

Antibe Therapeutics Receives Approval from Health Canada to Begin Human Clinical Testing
6/19/2014 7:45:00 AM - Business Wire

Record Number of Advantest V93000 and T2000 Customers and Partners Converge in Silicon Valley, CA and Austin, TX for Annual VOICE Developer Conference
6/10/2014 3:05:00 AM - Market Wire

Advantest Introduces EVA100 Measurement System for Testing Analog, Mixed-Signal and Sensor ICs
5/27/2014 3:05:00 AM - Market Wire

Advantest Earns 26th Consecutive Ranking as a Top IC Test Equipment Supplier, Excelling in Areas of Technical Leadership, Product Performance and Quality of Results
5/22/2014 9:00:00 AM - Business Wire

Antibe Therapeutics Announces Submission of Clinical Trial Application to Health Canada For ATB-346
5/21/2014 11:30:00 AM - Business Wire

Advantest Launches TAS5500 Terahertz Power Meter
5/14/2014 12:01:00 PM - Business Wire

Antibe Therapeutics Announces Addition to Its Board of Directors and Grant of Options
5/12/2014 7:30:00 AM - Business Wire

Advantest Installs Integrated Test Cell Using V93000 Platform to Test MEMS-Based Sensors for TPMS Applications
5/12/2014 3:05:00 AM - Market Wire

Antibe Therapeutics Inc. CEO Letter to Shareholders
5/5/2014 7:30:00 AM - Business Wire